U S Physical Therapy Inc. (USPH) stock forecast and price target
Price $99.60 · data as of November 13, 2026
12-month price target
Gold marker: average target · white marker: today’s price ($99.60)
Analyst ratings
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $2.88 | +9.6% | $860M |
| Next fiscal year ends December 31, 2027 | $3.37 | +16.8% | $932M |
| Next quarter ends December 31, 2026 | $0.88 | +31.0% | $225M |
| Quarter after ends March 31, 2027 | $0.56 | +21.7% | $220M |
Consensus of the analysts covering U S Physical Therapy, updated daily. In the last 30 days 0 estimates were raised and 1 lowered.
Our model vs. Wall Street
Analysts see 11.9% upside over 12 months. Our discounted cash flow model with moderate assumptions puts U S Physical Therapy’s intrinsic value about 23% below today’s market value, and it scores 2.4 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.
Frequently asked questions
What is the U S Physical Therapy stock price target?
The average 12-month target from 6 analysts is $111.50, 11.9% above the current price of $99.60 Targets range from $95.00 to $122.00.
Is U S Physical Therapy a buy according to analysts?
The consensus rating is “Buy” (4 strong buy, 2 buy, 1 hold). Ratings are opinions, not guarantees; this is not investment advice.
How much is U S Physical Therapy expected to earn?
Analysts expect EPS of $2.88 for the fiscal year ending December 31, 2026 and $3.37 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.